Bristol-Myers Squibb Co (STU:BRM) E10: €1.43 (As of Mar. 2026)


STU:BRM Bristol-Myers Squibb Co STU:BRM
78 GF Score
Price €49.62
GF Value €48.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Bristol-Myers Squibb Co E10?

Bristol-Myers Squibb Co STU:BRM -1.83% 78 E10 is €1.43 as of Mar. 2026. GuruFocus rates STU:BRM with a GF Score™ of 78/100 and a GF Value™ of €48.49 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted earnings per share data for the three months ended in Mar. 2026 was €1.133. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €1.43 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bristol-Myers Squibb Co's average E10 Growth Rate was 19.40% per year. During the past 3 years, the average E10 Growth Rate was -1.20% per year. During the past 5 years, the average E10 Growth Rate was 3.20% per year. During the past 10 years, the average E10 Growth Rate was -3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bristol-Myers Squibb Co was 14.10% per year. The lowest was -16.40% per year. And the median was 1.90% per year.

As of today (2026-07-02), Bristol-Myers Squibb Co's current stock price is €49.615. Bristol-Myers Squibb Co's E10 for the quarter that ended in Mar. 2026 was €1.43. Bristol-Myers Squibb Co's Shiller PE Ratio of today is 34.70.

During the past 13 years, the highest Shiller PE Ratio of Bristol-Myers Squibb Co was 54.46. The lowest was 18.28. And the median was 33.60.


Bristol-Myers Squibb Co  (STU:BRM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bristol-Myers Squibb Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=49.615/1.43
=34.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Bristol-Myers Squibb Co was 54.46. The lowest was 18.28. And the median was 33.60.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bristol-Myers Squibb Co E10 Related Terms


Bristol-Myers Squibb Co E10 Historical Data

* Premium members only.

The historical data trend for Bristol-Myers Squibb Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co E10 Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.25 1.55 1.72 1.31 1.36

Bristol-Myers Squibb Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 1.26 1.30 1.36 1.43

STU:BRM vs PFE, GILD, AMGN: E10 Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Shiller PE Ratio falls into.


STU:BRM
78GF Score
Bristol-Myers Squibb Co STU:BRM
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bristol-Myers Squibb Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bristol-Myers Squibb Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.133/330.2130*330.2130
=1.133

Current CPI (Mar. 2026) = 330.2130.

Bristol-Myers Squibb Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.614 241.018 0.841
201609 0.642 241.428 0.878
201612 0.502 241.432 0.687
201703 0.879 243.801 1.191
201706 0.498 244.955 0.671
201709 0.428 246.819 0.573
201712 -1.191 246.524 -1.595
201803 0.738 249.554 0.977
201806 0.197 251.989 0.258
201809 0.994 252.439 1.300
201812 0.642 251.233 0.844
201903 0.920 254.202 1.195
201906 0.770 256.143 0.993
201909 0.754 256.759 0.970
201912 -0.495 256.974 -0.636
202003 -0.308 258.115 -0.394
202006 -0.036 257.797 -0.046
202009 0.696 260.280 0.883
202012 -3.658 260.474 -4.637
202103 0.748 264.877 0.933
202106 0.390 271.696 0.474
202109 0.587 274.310 0.707
202112 0.947 278.802 1.122
202203 0.536 287.504 0.616
202206 0.624 296.311 0.695
202209 0.758 296.808 0.843
202212 0.897 296.797 0.998
202303 0.999 301.836 1.093
202306 0.914 305.109 0.989
202309 0.871 307.789 0.934
202312 0.798 306.746 0.859
202403 -5.419 312.332 -5.729
202406 0.771 314.175 0.810
202409 0.541 315.301 0.567
202412 0.038 315.605 0.040
202503 1.110 319.799 1.146
202506 0.555 322.561 0.568
202509 0.920 324.800 0.935
202512 0.453 324.054 0.462
202603 1.133 330.213 1.133

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €1.43 mean?
Bristol-Myers Squibb Co (STU:BRM) has a E10 of €1.43 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors.
Is Bristol-Myers Squibb Co's E10 too high?
Bristol-Myers Squibb Co's current E10 is €1.43. Overall, Bristol-Myers Squibb Co has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bristol-Myers Squibb Co's E10 compare to PFE and GILD?
Bristol-Myers Squibb Co's E10 of €1.43 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors. Bristol-Myers Squibb Co's current E10 is €1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bristol-Myers Squibb Co stock overvalued right now?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co (STU:BRM) is currently considered Fairly Valued. The stock's GF Value™ is €48.49, compared to a current price of €49.62 — trading 2.3% above its estimated fair value. The current E10 is €1.43. Bristol-Myers Squibb Co's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Bristol-Myers Squibb Co (STU:BRM), the current E10 is €1.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bristol-Myers Squibb Co (STU:BRM) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of €49.62 is trading 2.3% above its estimated GF Value™ of €48.49. GuruFocus considers Bristol-Myers Squibb Co to be Fairly Valued.

Key valuation signals for STU:BRM:

  • E10: €1.43
  • GF Value™: €48.49 vs. price of €49.62 (2.3% above fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the STU:BRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bristol-Myers Squibb Co Business Description

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
78GF Score

Get the complete analysis for STU:BRM

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€49.62
Price
€48.49
GF Value